Tags

Type your tag names separated by a space and hit enter

Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
Hepatology. 2007 Apr; 45(4):879-85.Hep

Abstract

Minimal hepatic encephalopathy (MHE) is mainly diagnosed using psychometric tests such as the psychometric hepatic encephalopathy score (PHES). Despite the clinical and social relevance of MHE, psychometric testing is not widespread in routine clinical care. We assessed the usefulness of the critical flicker frequency (CFF), for the diagnosis of MHE and for the prediction of the development of overt episodes of HE. The normal range of PHES in the Spanish population was evaluated in a control group. Subsequently, 114 patients with cirrhosis and 103 healthy controls underwent both PHES and CFF tests. A diagnosis of MHE was made when the PHES was lower than -4 points. Patients were followed-up every 6 months for a total of 1 year. CFF did not correlate with age, education, or sex in the control group. The mean CFF was significantly lower in patients with MHE versus non-MHE or controls. Mean CFF correlated with individual psychometric tests as well as PHES (r = 0.54; P < 0.001). CFF <38 Hz was predictive of further bouts of overt HE (log-rank: 14.2; P < 0.001). There was a weak correlation between mean CFF and Child-Pugh score but not with model for end-stage liver disease score. In multivariate analysis using Cox regression, CFF together with Child-Pugh score was independently associated with the development of overt HE.

CONCLUSION

CFF is a simple, reliable, and accurate method for the diagnosis of MHE. It is not influenced by age or education and could predict the development of overt HE.

Authors+Show Affiliations

Unit for the Clinical Management of Digestive Diseases, Hospital Universitario de Valme, Sevilla, Spain. mromerog@supercable.esNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17393525

Citation

Romero-Gómez, Manuel, et al. "Value of the Critical Flicker Frequency in Patients With Minimal Hepatic Encephalopathy." Hepatology (Baltimore, Md.), vol. 45, no. 4, 2007, pp. 879-85.
Romero-Gómez M, Córdoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45(4):879-85.
Romero-Gómez, M., Córdoba, J., Jover, R., del Olmo, J. A., Ramírez, M., Rey, R., de Madaria, E., Montoliu, C., Nuñez, D., Flavia, M., Compañy, L., Rodrigo, J. M., & Felipo, V. (2007). Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology (Baltimore, Md.), 45(4), 879-85.
Romero-Gómez M, et al. Value of the Critical Flicker Frequency in Patients With Minimal Hepatic Encephalopathy. Hepatology. 2007;45(4):879-85. PubMed PMID: 17393525.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. AU - Romero-Gómez,Manuel, AU - Córdoba,Juan, AU - Jover,Rodrigo, AU - del Olmo,Juan A, AU - Ramírez,Marta, AU - Rey,Ramón, AU - de Madaria,Enrique, AU - Montoliu,Carmina, AU - Nuñez,David, AU - Flavia,Montse, AU - Compañy,Luis, AU - Rodrigo,José M, AU - Felipo,Vicente, PY - 2007/3/30/pubmed PY - 2007/5/30/medline PY - 2007/3/30/entrez SP - 879 EP - 85 JF - Hepatology (Baltimore, Md.) JO - Hepatology VL - 45 IS - 4 N2 - UNLABELLED: Minimal hepatic encephalopathy (MHE) is mainly diagnosed using psychometric tests such as the psychometric hepatic encephalopathy score (PHES). Despite the clinical and social relevance of MHE, psychometric testing is not widespread in routine clinical care. We assessed the usefulness of the critical flicker frequency (CFF), for the diagnosis of MHE and for the prediction of the development of overt episodes of HE. The normal range of PHES in the Spanish population was evaluated in a control group. Subsequently, 114 patients with cirrhosis and 103 healthy controls underwent both PHES and CFF tests. A diagnosis of MHE was made when the PHES was lower than -4 points. Patients were followed-up every 6 months for a total of 1 year. CFF did not correlate with age, education, or sex in the control group. The mean CFF was significantly lower in patients with MHE versus non-MHE or controls. Mean CFF correlated with individual psychometric tests as well as PHES (r = 0.54; P < 0.001). CFF <38 Hz was predictive of further bouts of overt HE (log-rank: 14.2; P < 0.001). There was a weak correlation between mean CFF and Child-Pugh score but not with model for end-stage liver disease score. In multivariate analysis using Cox regression, CFF together with Child-Pugh score was independently associated with the development of overt HE. CONCLUSION: CFF is a simple, reliable, and accurate method for the diagnosis of MHE. It is not influenced by age or education and could predict the development of overt HE. SN - 0270-9139 UR - https://www.unboundmedicine.com/medline/citation/17393525/Value_of_the_critical_flicker_frequency_in_patients_with_minimal_hepatic_encephalopathy_ L2 - https://doi.org/10.1002/hep.21586 DB - PRIME DP - Unbound Medicine ER -